FindTrial
Sign In

what happens when a patient having connective tissue disease develops covid 19 infection.

Covid-19 outcome in patients with Connective Tissue Disease with or without Interstitial Lung Disease.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029761
Enrollment
30
Registered
2020-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: NIL: NIL

Sponsors

PRATIMA SINGH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -All cases of Connective Tissue Disease with interstitial lung disease associated with Covid19 infection -All cases of Connective Tissue Disease without interstitial lung disease associated with Covid19 infection

Exclusion criteria

Exclusion criteria: 1. Co-morbidity like Chronic Kidney Disease,Chronic Liver Disesase. 2. Patient who does not give consent for study.

Design outcomes

Primary

MeasureTime frame
CT THORAX SEVERITY SCORETimepoint: 0 AND 12WEEKS—

Secondary

MeasureTime frame
6MinuteWalkDistance,ErythrocyteSedimentationRateTimepoint: 0,12WEEKS—

Countries

India

Contacts

Public ContactPratima Singh

KALINGA INSTITUTE OF MEDICAL SCIENCES

drppratima@gmail.com8895613285

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026